Guardion Health Sciences (NASDAQ:GHSI) Stock Price Down 18.8%

Guardion Health Sciences Inc (NASDAQ:GHSI) dropped 18.8% during mid-day trading on Thursday . The company traded as low as $0.41 and last traded at $0.52, approximately 20,772,061 shares changed hands during trading. An increase of 669% from the average daily volume of 2,701,818 shares. The stock had previously closed at $0.64.

The company’s fifty day moving average price is $0.45. The company has a debt-to-equity ratio of 0.10, a quick ratio of 4.80 and a current ratio of 5.40.

Guardion Health Sciences (NASDAQ:GHSI) last announced its quarterly earnings results on Monday, August 12th. The company reported ($0.14) earnings per share (EPS) for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 780.75% and a negative return on equity of 243.25%.

About Guardion Health Sciences (NASDAQ:GHSI)

Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Further Reading: How accurate is the Rule of 72?

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.